Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > New info?

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Oct 09, 2024 1:03pm

97 Views

Post# 36259595

RE:New info?

VM just has too much going for it to be sitting at this share price. Do not forget that the projections were at a much lower price and a conservative share of market. If tese new contrast agents work out what might the % of market share be? Also that Latin America deal was just for SmoothX 2%.. I hope we are all well rewarded for our patience.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market